Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer

Bibliographic Details
Main Authors:	Olofsson, Sven-Erik, Nodin, Björn, Gaber, Alexander, Eberhard, Jakob, Uhlén, Mathias, Jirström, Karin, Jerkeman, Mats
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374873/

Similar Items

Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma
by: Fristedt, Richard, et al.
Published: (2014)

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
by: Jonsson, Liv, et al.
Published: (2014)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
by: Jonsson, Liv, et al.
Published: (2011)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
by: Nodin, Björn, et al.
Published: (2012)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
by: Elebro, Jacob, et al.
Published: (2014)

SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
by: Hedner, Charlotta, et al.
Published: (2014)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
by: Jonsson, Liv, et al.
Published: (2011)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
by: Bengtsson, Erik, et al.
Published: (2014)

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
by: Berntsson, Jonna, et al.
Published: (2014)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
by: Heby, Margareta, et al.
Published: (2015)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
by: Fristedt, Richard, et al.
Published: (2014)

Prognostic factors of metastatic testicular non-seminomatous germ cell tumors after chemotherapy
by: Tzu-Yao Liao, et al.
Published: (2018-09-01)

Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
by: Borg, David, et al.
Published: (2016)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
by: Larsson, Anna H, et al.
Published: (2013)

Surgery in metastatic non-seminomatous germ cell tumours.
by: Tobias, J. S.
Published: (1992)

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
by: Wangefjord, Sakarias, et al.
Published: (2011)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
by: Nodin, Björn, et al.
Published: (2012)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
by: Nodin, Björn, et al.
Published: (2012)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
by: Nodin, Björn, et al.
Published: (2012)

Testicular seminomatous mixed germ cell tumor with choriocarcinoma and teratoma with secondary somatic malignancy: a case report
by: Aneja, Amandeep, et al.
Published: (2014)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
by: Eberhard, J, et al.
Published: (2012)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
by: Cassidy, J., et al.
Published: (1992)

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
by: Harding, M., et al.
Published: (1995)

Non-Seminomatous Germ Cell Tumor Metastasis to the Jaw: An Imaging Case Report
by: Siverino, Rita Olivia, et al.
Published: (2016)

The management of low-stage non-seminomatous germ cell tumors
by: Lim, Louise, et al.
Published: (2012)

Compliance with follow-up of patients treated for non-seminomatous testicular cancer.
by: Young, B. J., et al.
Published: (1991)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
by: Larsson, Anna, et al.
Published: (2012)

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
by: Andersson, Gustav, et al.
Published: (2014)

Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
by: Wangefjord, Sakarias, et al.
Published: (2013)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
by: Borg, David, et al.
Published: (2016)

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma
by: Hedner, Charlotta, et al.
Published: (2016)

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma
by: Elebro, Jacob, et al.
Published: (2016)

Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
by: Elebro, Jacob, et al.
Published: (2016)

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
by: Tait, D., et al.
Published: (1984)

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
by: Larsson, Anna H., et al.
Published: (2016)

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
by: Raghavan, D., et al.
Published: (1982)

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
by: de Wit, R., et al.
Published: (1998)

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
by: Wennersten, Christoffer, et al.
Published: (2014)

Influence of anthropometric factors on tumour biological characteristics of colorectal cancer in men and women: a cohort study
by: Brändstedt, Jenny, et al.
Published: (2013)

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
by: Brändstedt, Jenny, et al.
Published: (2014)